Logo image of AMPX

AMPRIUS TECHNOLOGIES INC (AMPX) Stock Fundamental Analysis

NYSE:AMPX - US03214Q1085 - Common Stock

7.09 USD
-0.29 (-3.93%)
Last: 8/29/2025, 8:06:20 PM
7.0206 USD
-0.07 (-0.98%)
After Hours: 8/29/2025, 8:06:20 PM
Fundamental Rating

4

Taking everything into account, AMPX scores 4 out of 10 in our fundamental rating. AMPX was compared to 93 industry peers in the Electrical Equipment industry. AMPX has a great financial health rating, but its profitability evaluates not so good. AMPX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year AMPX has reported negative net income.
In the past year AMPX has reported a negative cash flow from operations.
AMPX had negative earnings in each of the past 5 years.
In the past 5 years AMPX always reported negative operating cash flow.
AMPX Yearly Net Income VS EBIT VS OCF VS FCFAMPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

AMPX's Return On Assets of -30.89% is on the low side compared to the rest of the industry. AMPX is outperformed by 62.37% of its industry peers.
The Return On Equity of AMPX (-49.59%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -30.89%
ROE -49.59%
ROIC N/A
ROA(3y)-30.62%
ROA(5y)-51.34%
ROE(3y)-49.84%
ROE(5y)-171.03%
ROIC(3y)N/A
ROIC(5y)N/A
AMPX Yearly ROA, ROE, ROICAMPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

AMPX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMPX Yearly Profit, Operating, Gross MarginsAMPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -100 -200 -300 -400

8

2. Health

2.1 Basic Checks

AMPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AMPX has more shares outstanding
There is no outstanding debt for AMPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AMPX Yearly Shares OutstandingAMPX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AMPX Yearly Total Debt VS Total AssetsAMPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

AMPX has an Altman-Z score of 9.72. This indicates that AMPX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 9.72, AMPX belongs to the best of the industry, outperforming 93.55% of the companies in the same industry.
There is no outstanding debt for AMPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.72
ROIC/WACCN/A
WACC8.87%
AMPX Yearly LT Debt VS Equity VS FCFAMPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

AMPX has a Current Ratio of 5.95. This indicates that AMPX is financially healthy and has no problem in meeting its short term obligations.
AMPX has a Current ratio of 5.95. This is amongst the best in the industry. AMPX outperforms 91.40% of its industry peers.
AMPX has a Quick Ratio of 5.59. This indicates that AMPX is financially healthy and has no problem in meeting its short term obligations.
AMPX has a Quick ratio of 5.59. This is amongst the best in the industry. AMPX outperforms 91.40% of its industry peers.
Industry RankSector Rank
Current Ratio 5.95
Quick Ratio 5.59
AMPX Yearly Current Assets VS Current LiabilitesAMPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

AMPX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.67%, which is quite impressive.
Looking at the last year, AMPX shows a very strong growth in Revenue. The Revenue has grown by 260.86%.
Measured over the past years, AMPX shows a very strong growth in Revenue. The Revenue has been growing by 105.86% on average per year.
EPS 1Y (TTM)26.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
Revenue 1Y (TTM)260.86%
Revenue growth 3Y105.86%
Revenue growth 5YN/A
Sales Q2Q%350.43%

3.2 Future

Based on estimates for the next years, AMPX will show a very strong growth in Earnings Per Share. The EPS will grow by 21.51% on average per year.
The Revenue is expected to grow by 96.28% on average over the next years. This is a very strong growth
EPS Next Y41.38%
EPS Next 2Y35.32%
EPS Next 3Y24.76%
EPS Next 5Y21.51%
Revenue Next Year195.88%
Revenue Next 2Y183.64%
Revenue Next 3Y116.31%
Revenue Next 5Y96.28%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AMPX Yearly Revenue VS EstimatesAMPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
AMPX Yearly EPS VS EstimatesAMPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 -0.4 0.6 0.8

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMPX. In the last year negative earnings were reported.
Also next year AMPX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMPX Price Earnings VS Forward Price EarningsAMPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMPX Per share dataAMPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

AMPX's earnings are expected to grow with 24.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.32%
EPS Next 3Y24.76%

0

5. Dividend

5.1 Amount

No dividends for AMPX!.
Industry RankSector Rank
Dividend Yield N/A

AMPRIUS TECHNOLOGIES INC

NYSE:AMPX (8/29/2025, 8:06:20 PM)

After market: 7.0206 -0.07 (-0.98%)

7.09

-0.29 (-3.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners22.8%
Inst Owner Change79.7%
Ins Owners6.81%
Ins Owner Change2.74%
Market Cap886.82M
Analysts84.62
Price Target13.26 (87.02%)
Short Float %9.16%
Short Ratio1.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.01%
Min EPS beat(2)14.22%
Max EPS beat(2)39.8%
EPS beat(4)4
Avg EPS beat(4)20.75%
Min EPS beat(4)8.49%
Max EPS beat(4)39.8%
EPS beat(8)7
Avg EPS beat(8)11.5%
EPS beat(12)9
Avg EPS beat(12)9.9%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)22.7%
Min Revenue beat(2)15.54%
Max Revenue beat(2)29.85%
Revenue beat(4)4
Avg Revenue beat(4)38.28%
Min Revenue beat(4)15.54%
Max Revenue beat(4)82.72%
Revenue beat(8)8
Avg Revenue beat(8)73.33%
Revenue beat(12)11
Avg Revenue beat(12)71.31%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)27.87%
PT rev (3m)36.84%
EPS NQ rev (1m)23.64%
EPS NQ rev (3m)46.67%
EPS NY rev (1m)18.43%
EPS NY rev (3m)19.3%
Revenue NQ rev (1m)8.92%
Revenue NQ rev (3m)21.7%
Revenue NY rev (1m)2.16%
Revenue NY rev (3m)4.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.78
P/FCF N/A
P/OCF N/A
P/B 11.57
P/tB 11.57
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.36
BVpS0.61
TBVpS0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.89%
ROE -49.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.62%
ROA(5y)-51.34%
ROE(3y)-49.84%
ROE(5y)-171.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.9%
Cap/Sales 1.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.95
Quick Ratio 5.59
Altman-Z 9.72
F-Score6
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)384.03%
Cap/Depr(5y)247.44%
Cap/Sales(3y)80.23%
Cap/Sales(5y)54.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
EPS Next Y41.38%
EPS Next 2Y35.32%
EPS Next 3Y24.76%
EPS Next 5Y21.51%
Revenue 1Y (TTM)260.86%
Revenue growth 3Y105.86%
Revenue growth 5YN/A
Sales Q2Q%350.43%
Revenue Next Year195.88%
Revenue Next 2Y183.64%
Revenue Next 3Y116.31%
Revenue Next 5Y96.28%
EBIT growth 1Y10.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.18%
EBIT Next 3Y45.62%
EBIT Next 5Y38.19%
FCF growth 1Y-35.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.12%
OCF growth 3YN/A
OCF growth 5YN/A